International Paper Q3 2022 adjusted EPS $1.01 misses Q2's $1.24; revenue up 10% YoY to $5.4B

INTERNATIONAL PAPER CO /NEW/

2022-Q3 EPS reported $4.92 revenue$16,028,000,000

Net earnings from continuing ops $951M ($2.64 diluted) include $563M tax benefit from timber settlement.
Adjusted operating earnings $364M ($1.01 diluted), down from $459M ($1.24) in Q2 2022.
Industrial Packaging operating profit $369M, down from $560M Q2 on lower volumes and higher costs.
Global Cellulose Fibers operating profit $95M vs $25M Q2, driven by higher prices and volumes.
Cash from ops $435M; returned $434M to shareholders via $269M buybacks and $165M dividends.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

INTERNATIONAL PAPER CO /NEW/ reported the fiscal quarter ended September 30, 2022 results: revenue $5,402, net income $951 million ($2.64 per diluted share), EPS $2.64.

Period: the fiscal quarter ended September 30, 2022
Revenue: $5,402
Net income: $951 million ($2.64 per diluted share)
EPS: $2.64
Result: reported results

Exact text from the filing

of Operations and related notes included later in this release. Select Financial Measures (In millions) Third Quarter 2022 Second Quarter 2022 Third Quarter 2021 Net Sales $ 5,402 $ 5,389 $ 4,914 Net Earnings (Loss) Attributable to International Paper 951 511 864 Business Segment Operating Profit 464 585 490 Adjusted Operating Earnings 364 459 431 Cash

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

INTERNATIONAL PAPER CO /NEW/ filing history →

Source: SEC EDGAR

accession 0000051434-22-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.